Cargando…

Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence

With the lack of effective therapy, chemoprevention and vaccination, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Interestingly, montelukast, a drug usually used in asthma, may be proposed as a potential adjuvant therapy in COVID-19. The aim of the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Barré, Jean, Sabatier, Jean-Marc, Annweiler, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500361/
https://www.ncbi.nlm.nih.gov/pubmed/33013375
http://dx.doi.org/10.3389/fphar.2020.01344